Correlation Between OBI Pharma and Lotus Pharmaceutical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both OBI Pharma and Lotus Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining OBI Pharma and Lotus Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between OBI Pharma and Lotus Pharmaceutical Co, you can compare the effects of market volatilities on OBI Pharma and Lotus Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in OBI Pharma with a short position of Lotus Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of OBI Pharma and Lotus Pharmaceutical.

Diversification Opportunities for OBI Pharma and Lotus Pharmaceutical

-0.38
  Correlation Coefficient

Very good diversification

The 3 months correlation between OBI and Lotus is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding OBI Pharma and Lotus Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lotus Pharmaceutical and OBI Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on OBI Pharma are associated (or correlated) with Lotus Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lotus Pharmaceutical has no effect on the direction of OBI Pharma i.e., OBI Pharma and Lotus Pharmaceutical go up and down completely randomly.

Pair Corralation between OBI Pharma and Lotus Pharmaceutical

Assuming the 90 days trading horizon OBI Pharma is expected to under-perform the Lotus Pharmaceutical. In addition to that, OBI Pharma is 1.06 times more volatile than Lotus Pharmaceutical Co. It trades about -0.19 of its total potential returns per unit of risk. Lotus Pharmaceutical Co is currently generating about -0.02 per unit of volatility. If you would invest  26,950  in Lotus Pharmaceutical Co on September 14, 2024 and sell it today you would lose (850.00) from holding Lotus Pharmaceutical Co or give up 3.15% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

OBI Pharma  vs.  Lotus Pharmaceutical Co

 Performance 
       Timeline  
OBI Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days OBI Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.
Lotus Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Lotus Pharmaceutical Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Lotus Pharmaceutical is not utilizing all of its potentials. The current stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

OBI Pharma and Lotus Pharmaceutical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with OBI Pharma and Lotus Pharmaceutical

The main advantage of trading using opposite OBI Pharma and Lotus Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if OBI Pharma position performs unexpectedly, Lotus Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lotus Pharmaceutical will offset losses from the drop in Lotus Pharmaceutical's long position.
The idea behind OBI Pharma and Lotus Pharmaceutical Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Other Complementary Tools

Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Transaction History
View history of all your transactions and understand their impact on performance
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk